However, HO-1 expression was found to be decreased in patients with early-stage non-small cell lung cancer (125) and its induction increased cell death and inhibited the migratory ability of hepatocellular carcinoma (HCC) cells (126, 127), suggesting tumor type specific effects. This evidence concerns the gene HMOX1 and neoplasm.